BAFNA PHARMACEUTICALS
Back to Income Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹152 Cr | ₹115 Cr | ₹85 Cr | ₹71 Cr | ₹42 Cr |
What is the latest Revenue of BAFNA PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹152 Cr |
| Mar2024 | ₹115 Cr |
| Mar2023 | ₹85 Cr |
| Mar2022 | ₹71 Cr |
| Mar2021 | ₹42 Cr |
How is Revenue of BAFNA PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹152 Cr | 32.18 | |
| Mar2024 | ₹115 Cr | 35.48 | |
| Mar2023 | ₹85 Cr | 19.55 | |
| Mar2022 | ₹71 Cr | 67.68 | |
| Mar2021 | ₹42 Cr | - | |
Compare Revenue of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹252.6 Cr | -5.3% | -1.1% | 40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -5.3% |
-1.1% |
40.2% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses